XML 28 R14.htm IDEA: XBRL DOCUMENT v3.19.1
Note 6 - Employee Benefit Plans
12 Months Ended
Dec. 29, 2018
Notes to Financial Statements  
Disclosure of Compensation Related Costs, Share-based Payments [Text Block]
6.
Employee Benefit Plans
 
Defined Contribution Retirement Plans
– Cohu and Xcerra each maintain defined contribution
401
(k) retirement savings plans covering all their respective salaried and hourly U.S. employees.  Participation is voluntary and participants’ contributions are based on their eligible compensation. Participants in the Cohu plan receive matching contributions of
50%
up to
8%
of salary contributed and participants in the Xcerra plan receive matching contributions of
50%
up to
6%
of salary contributed, both subject to various statutory limits.  In
2018
we made matching contributions to the plan of
$1.1
 million which includes matching contributions to the Xcerra
401
(k) plan from
October 1
through
December 29, 2018.
In both
2017
and
2016
we made contributions to the plan of
$0.6
 million.
 
Defined Benefit Retirement Plans
– As a result of the acquisition of Ismeca effective
December 31, 2012,
we took over the Ismeca Europe Semiconductor BVG Pension Plan in Switzerland (“the Swiss Plan”) and the following discussion only relates to the Swiss Plan.
 
Net periodic benefit cost of the Swiss Plan was as follows:
 
(in thousands)
 
2018
   
2017
   
2016
 
Service cost
  $
925
    $
907
    $
868
 
Interest cost
   
207
     
198
     
245
 
Expected return on assets
   
(124
)    
(119
)    
(147
)
Net periodic costs
  $
1,008
    $
986
    $
966
 
 
The following table sets forth the projected benefit obligation, the fair value of plan assets, the funded status and the liability we have recorded in our consolidated balance sheet related to the Swiss Plan:
 
(in thousands)
 
2018
   
2017
 
Change in projected benefit obligation:
               
Benefit obligation at beginning of year
  $
(30,512
)   $
(27,499
)
Service cost
   
(925
)    
(907
)
Interest cost
   
(207
)    
(198
)
Actuarial gain (loss)
   
708
     
(628
)
Participant contributions
   
(816
)    
(789
)
Benefits paid
   
1,079
     
743
 
Plan change
   
199
     
-
 
Foreign currency exchange adjustment
   
564
     
(1,234
)
Benefit obligation at end of year
   
(29,910
)    
(30,512
)
Change in plan assets:
               
Fair value of plan assets at beginning of year
   
17,746
     
16,077
 
Return on assets, net of actuarial loss
   
114
     
112
 
Employer contributions
   
816
     
789
 
Participant contributions
   
816
     
789
 
Benefits paid
   
(1,079
)    
(743
)
Foreign currency exchange adjustment
   
(325
)    
722
 
Fair value of plan assets at end of year
   
18,088
     
17,746
 
Net liability at end of year
  $
(11,822
)   $
(12,766
)
 
At
December 29, 2018
and
December 30, 2017,
the Swiss Plan’s net liability is included in noncurrent accrued retirement benefits. Amounts recognized in accumulated other comprehensive income net of tax related to the Swiss Plan consisted of an unrecognized net actuarial loss totaling
$2.7
million at
December 29, 2018,
and
$3.1
million at
December 30, 2017.
 
Weighted-average actuarial assumptions used to determine the projected benefit obligation under the Swiss Plan are as follows:
   
2018
   
2017
 
Discount rate
   
0.9
%    
0.7
%
Compensation increase
   
1.8
%    
1.8
%
 
Weighted-average assumptions used to determine net periodic benefit cost of the Swiss Plan are as follows:
 
   
2018
   
2017
   
2016
 
Discount rate
   
0.7
%    
0.7
%    
1.0
%
Rate of return on Assets
   
0.7
%    
0.7
%    
1.0
%
Compensation increase
   
1.8
%    
1.5
%    
1.8
%
 
During 
2019
employer and employee contributions to the Swiss Plan are expected to total
$0.8
 million. Estimated benefit payments are expected to be as follows:
2019
-
$0.7
 million;
2020
-
$0.9
 million;
2021
-
$1.0
 million;
2022
-
$0.8
 million;
2023
-
$1.3
 million; and
$5.9
 million thereafter through
2028.
 
As is customary with Swiss pension plans, the assets of the plan are invested in a collective fund with multiple employers. We have
no
investment authority over the assets of the plan that are held and invested by a Swiss insurance company. Investment holdings are made with respect to Swiss laws and target allocations for plan assets are
67%
debt securities and cash,
16%
real estate investments,
8%
alternative investments and
9%
equity securities. The valuation of the collective fund assets as a whole is a Level
3
measurement; however the individual investments of the fund are generally Level
1
(equity securities), Level
2
(fixed income) and Level
3
(real estate and alternative) investments. We determine the fair value of the plan assets based on information provided by the collective fund, through review of the collective fund’s annual financial statements. See Note
7,
“Financial Instruments Measured at Fair Value” for additional information on the
three
-tier fair value hierarchy.
 
We maintain other defined benefit plans for employees located outside the U.S. for which the majority of the obligations and net periodic benefit cost were determined to be immaterial for all periods presented.
 
Retiree Medical Benefits
– We provide post-retirement health benefits to certain executives and directors under a noncontributory plan. The net periodic benefit cost was
$0.1
 million in
2018,
2017,
and
2016.
We fund benefits as costs are incurred and as a result there are
no
plan assets.
 
The weighted average discount rate used in determining the accumulated post-retirement benefit obligation was
4.1%
in
2018,
3.4%
in
2017
and
3.9%
in
2016.
The annual rates of increase of the cost of health benefits was assumed to be
8.8%
in
2019.
This rate was then assumed to decrease
0.6%
per year to
4.4%
in
2027
and remain level thereafter. A
one
percent increase (decrease) in health care cost trend rates would increase (decrease) the
2018
net periodic benefit cost by approximately
$14,000
(
$12,000
) and the accumulated post-retirement benefit obligation as of
December 29, 2018,
by approximately
$349,000
(
$298,000
).
 
Contributions to the post-retirement health benefit plan are expected to total
$0.1
million in 
2019.
Estimated benefit payments are expected to be as follows:
2019
-
$0.1
million;
2020
-
$0.1
million;
2021
-
$0.1
million;
2022
-
$0.2
million;
2023
-
$0.2
million and
$0.9
million thereafter through
2027.
 
The following table sets forth the post-retirement benefit obligation, funded status and the liability we have recorded in our consolidated balance sheets:
 
(in thousands)
 
2018
   
2017
 
Accumulated benefit obligation at beginning of year
  $
3,148
    $
2,490
 
Interest cost
   
105
     
95
 
Actuarial (gain) loss
   
(216
)    
677
 
Benefits paid
   
(157
)    
(114
)
Accumulated benefit obligation at end of year
   
2,880
     
3,148
 
Plan assets at end of year
   
-
     
-
 
Funded status
  $
(2,880
)   $
(3,148
)
 
Deferred Compensation
– The Cohu, Inc. Deferred Compensation Plan allows certain of our officers to defer a portion of their current compensation. We have purchased life insurance policies on the participants with Cohu as the named beneficiary. Participant contributions, distributions and investment earnings and losses are accumulated in a separate account for each participant. At
December 29, 2018,
the payroll liability to participants, included in accrued compensation and benefits in the consolidated balance sheet, was approximately
$2.0
 million and the cash surrender value of the related life insurance policies included in other current assets was approximately
$1.6
 million. At
December 30, 2017,
the liability totaled
$2.3
 million and the corresponding assets were
$2.2
 million.
 
Employee Stock Purchase Plan
– The Cohu, Inc.
1997
Employee Stock Purchase Plan (“the Plan”) provides for the issuance of a maximum of
2,650,000
shares of our common stock. Under the Plan, eligible employees
may
purchase shares of common stock through payroll deductions. The price paid for the common stock is equal to
85%
of the fair market value of our common stock on specified dates. During the last
three
years we issued shares under the Plan as follows:
2018
-
84,678;
2017
-
99,144
and
2016
-
110,579.
At
December 29, 2018,
there were
598,610
 shares reserved for issuance under the Plan.
 
Stock Options
– At
December 29, 2018,
a total of
1,198,058
 shares were available for future equity grants under the Cohu, Inc.
2005
Equity Incentive Plan (“the
2005
Plan”). Under the
2005
Plan stock options
may
be granted to employees, consultants and outside directors to purchase a fixed number of shares of our common stock at prices
not
less than
100%
of the fair market value at the date of grant. Options generally vest and become exercisable after
one
year or in
four
annual increments beginning
one
year after the grant date and expire
ten
years from the grant date. We have historically issued new shares of Cohu common stock upon share option exercise.
 
During
2018,
2017
and
2016
no
stock options were granted and the activity under our share-based compensation plans was as follows:
 
   
2018
   
2017
   
2016
 
           
Wt. Avg.
           
Wt. Avg.
           
Wt. Avg.
 
(in thousands, except per share data)
 
Shares
   
Ex. Price
   
Shares
   
Ex. Price
   
Shares
   
Ex. Price
 
Outstanding, beginning of year
   
472
    $
10.20
     
1,641
    $
10.79
     
1,965
    $
11.25
 
Exercised
   
(67
)   $
10.10
     
(1,164
)   $
10.98
     
(101
)   $
7.89
 
Cancelled
   
-
    $
-
     
(5
)   $
20.73
     
(223
)   $
16.19
 
Outstanding, end of year
   
405
    $
10.22
     
472
    $
10.20
     
1,641
    $
10.79
 
                                                 
Options exercisable at year end
   
405
    $
10.22
     
469
    $
10.20
     
1,537
    $
10.85
 
 
The aggregate intrinsic value of options exercised was
$0.9
 million in
2018,
$10.1
 million in
2017,
and
$0.5
 million in
2016.
At
December 29, 2018,
the aggregate intrinsic value of options outstanding, vested and expected to vest and exercisable was
$2.3
 million.
 
Information about stock options outstanding at
December 29, 2018
is as follows
(options in thousands)
:
 
             
Options Outstanding
   
Options Exercisable
 
                     
Approximate
                         
                     
Wt. Avg.
                         
Range of
   
Number
   
Remaining
   
Wt. Avg.
   
Number
   
Wt. Avg.
 
Exercise Prices
   
Outstanding
   
Life (Years)
   
Ex. Price
   
Exercisable
   
Ex. Price
 
$
7.32
-
$
9.44
     
225
     
4.0
    $
9.35
     
225
    $
9.35
 
$
9.45
-
$
10.54
     
10
     
3.0
    $
10.54
     
10
    $
10.54
 
$
10.55
-
$
15.89
     
170
     
3.2
    $
11.34
     
170
    $
11.34
 
 
 
 
 
 
     
405
     
3.6
    $
10.22
     
405
    $
10.22
 
 
Restricted Stock Units
– Under our equity incentive plans, restricted stock units
may
be granted to employees, consultants and outside directors. Restricted stock units vest over a
one
-year,
two
-year or a
four
-year period from the date of grant. Prior to vesting, restricted stock units do
not
have dividend equivalent rights, do
not
have voting rights and the shares underlying the restricted stock units are
not
considered issued and outstanding. New shares of our common stock will be issued on the date the restricted stock units vest net of the statutory tax withholding requirements to be paid by us on behalf of our employees. As a result, the actual number of shares issued will be fewer than the actual number of RSUs outstanding at
December 29, 2018.
 
Restricted stock unit activity under our share-based compensation plans was as follows:
 
   
2018
   
2017
   
2016
 
           
Wt. Avg.
           
Wt. Avg.
           
Wt. Avg.
 
(in thousands, except per share data)
 
Units
   
Fair Value
   
Units
   
Fair Value
   
Units
   
Fair Value
 
Outstanding, beginning of year
   
981
    $
12.50
     
1,083
    $
10.50
     
1,078
    $
9.93
 
Granted
   
822
    $
23.70
     
353
    $
15.95
     
471
    $
11.25
 
Released
   
(500
)   $
13.10
     
(409
)   $
10.26
     
(409
)   $
9.90
 
Cancelled
   
(38
)   $
14.67
     
(46
)   $
11.85
     
(57
)   $
10.25
 
Outstanding, end of year
   
1,265
    $
19.48
     
981
    $
12.50
     
1,083
    $
10.50
 
 
RSUs granted in
2018
in the table above include the issuance of
529,995
assumed RSUs to Xcerra employees, based on a conversion formula.
 
Equity-Based Performance Stock Units
We grant performance stock units (“PSUs”) to certain senior executives as a part of our long-term equity compensation program. The performance criteria for the PSUs is based on a combination of the Company’s annualized Total Shareholder Return (“TSR”) for the performance period and the relative performance of the Company’s TSR compared with the annualized TSR of certain peer companies for the performance period.
 
The number of shares of common stock that will ultimately be issued to settle PSUs granted over the last
four
years is as follows:
 
Year Granted     Range of Awards     Performance Criteria Period (years)  
2018    
25%
-
200%
   
3
 
2017    
25%
-
200%
   
3
 
2016    
25%
-
200%
   
3
 
2015    
25%
-
200%
   
2
 
                 
PSUs granted in
2018,
2017
and
2016
vest
100%
on the
third
anniversary of their grant and PSUs granted in
2015
vested
50%
on the
second
and
third
anniversary of their grant, respectively.
 
We estimated the fair value of the PSUs using a Monte Carlo simulation model on the date of grant. Compensation expense is recognized over the derived service period. New shares of our common stock will be issued on the date the PSUs vest net of the minimum statutory tax withholding requirements to be paid by us on behalf of our employees. As a result, the actual number of shares issued will be fewer than the actual number of PSUs outstanding at
December 29, 2018.
 
PSU activity under our share-based compensation plans was as follows:
 
   
2018
   
2017
   
2016
 
           
Wt. Avg.
           
Wt. Avg.
           
Wt. Avg.
 
(in thousands, except per share data)
 
Units
   
Fair Value
   
Units
   
Fair Value
   
Units
   
Fair Value
 
Outstanding, beginning of year
   
334
    $
14.31
     
403
    $
11.04
     
376
    $
10.80
 
Granted
   
89
    $
24.32
     
185
    $
17.60
     
222
    $
11.38
 
Released
   
(41
)   $
9.92
     
(186
)   $
11.35
     
(172
)   $
11.27
 
Cancelled
   
(42
)   $
10.69
     
(68
)   $
11.94
     
(23
)   $
8.75
 
Outstanding, end of year
   
340
    $
17.89
     
334
    $
14.31
     
403
    $
11.04
 
 
Share-based Compensation
– We estimate the fair value of each share-based award on the grant date using the Black-Scholes and the Monte Carlo simulation valuation models. Option valuation models require the input of highly subjective assumptions and changes in the assumptions used can materially affect the grant date fair value of an award. These assumptions for the Black-Scholes model include the risk-free rate of interest, expected dividend yield, expected volatility, and the expected life of the award. The risk-free rate of interest is based on the U.S. Treasury rates appropriate for the expected term of the award as of the grant date. Expected dividends are based primarily on historical factors related to our common stock. Expected volatility is based on historic weekly stock price observations of our common stock during the period immediately preceding the share-based award grant that is equal in length to the award’s expected term. We believe that historical volatility is the best estimate of future volatility. Expected life of the award is based on historical option exercise data. The Monte Carlo simulation model incorporates assumptions for the risk-free interest rate, Cohu and the selected peer group price volatility, the correlation between Cohu and the selected index, and dividend yields. Share-based compensation expense related to restricted stock unit awards is calculated based on the market price of our common stock on the date of grant, reduced by the present value of dividends expected to be paid on our common stock prior to vesting of the restricted stock unit.
 
The following weighted average assumptions were used to value share-based awards granted:
 
Employee Stock Purchase Plan
 
2018
   
2017
   
2016
 
Dividend yield
 
1.1 %
   
1.4 %
   
2.0 %
 
Expected volatility
 
39.0 %
   
33.3 %
   
31.2 %
 
Risk-free interest rate
 
1.7 %
   
0.7 %
   
0.3 %
 
Expected term (years)
 
0.5
   
0.5
   
0.5
 
Weighted-average grant date fair value per share
 
$ 5.90
   
$ 4.63
   
$ 2.82
 
 
Restricted Stock Units
 
2018
   
2017
   
2016
 
Dividend yield
 
1.0 %
   
1.4 %
   
2.0 %
 
 
Reported share-based compensation is classified in the Consolidated Financial Statements as follows:
 
(in thousands)
 
2018
   
2017
   
2016
 
Cost of sales
  $
546
    $
423
    $
398
 
Research and development
   
1,717
     
1,054
     
1,292
 
Selling, general and administrative
   
7,790
     
5,530
     
5,453
 
Share-based compensation of continuing operations
   
10,053
     
7,007
     
7,143
 
Income tax benefit
   
(993
)    
(530
)    
(269
)
Total share-based compensation, net of tax
  $
9,060
    $
6,477
    $
6,874
 
 
Share based compensation presented above for the year ended
December 29, 2018,
excludes
$8.2
 million of compensation recorded related to the acceleration of RSU awards held by certain executive officers and the Board of Directors of Xcerra because of the change in control. This non-cash expense has been included in restructuring in our consolidated statements of operations.
 
We adopted ASU
2016
-
09
in the
fourth
quarter of
2016,
which among other items, provides an accounting policy election to account for forfeitures as they occur, rather than based on an estimate of expected forfeitures. We elected to account for forfeitures as they occur and therefore, share-based compensation expense for the years ended
December 29, 2018,
December 30, 2017,
and
December 31, 2016,
have been calculated based on actual forfeitures in our consolidated statement of operations, rather than our previous approach where the expense was net of estimated forfeitures determined at the grant date. The net cumulative effect of this change was recognized as a
$0.2
 million increase to paid-in capital and a decrease to retained earnings as of
December 26, 2015.
 
At
December 29, 2018,
we had approximately
$21.2
 million of pre-tax unrecognized compensation cost related to unvested restricted stock units and performance stock units which is expected to be recognized over a weighted-average period of approximately
2.4
 years.